Shareholders meeting

CONCORD BIOTECH LIMITED B-1601-1602, B-wing Mondeal Heights, Iskcon Cross Road, S. G. Highway, Ahmedabad-380015, Gujarat. Phone : +91-79-68138700 Fax : +91-79-68138725 CIN No.: L24230GJ1984PLC007440 Email ID: complianceofficer@concordbiotech.com July 07, 2026 To To The Manager, Listing Department General Manager, Listing Department National Stock Exchange of India Limited BSE Limited Plot No. C/1 G Block, Phiroze Jeejeebhoy Towers, Bandra-Kurla Complex, Bandra (East), Dalal Street, Mumbai -400 051 Mumbai – 400 001 Symbol: CONCORDBIO Scrip Code: 543960 Sub.: Notice of 41st Annual General Meeting of the Company for the Financial Year 2025-26 Dear Sir / Madam, This is to inform you that the 41st Annual General Meeting (AGM) of the Company is scheduled to be held on Friday, July 31, 2026 through Video Conferencing (“VC”) or Other Audio-Visual Means (“OAVM”) at 12:00 Noon to transact the businesses as mentioned in the Notice of AGM. Pursuant to Regulation 34(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Notice of the Annual General Meeting (AGM) for the Financial Year 2025–26 is enclosed herewith. The Notice of AGM is also available on the Company’s website. It is further informed that the Company has fixed Friday, July 24, 2026 as the Cut-off date for ascertaining the names of the Members, who will be entitled to cast their votes electronically in respect of the businesses to be transacted as per the Notice of the AGM and for payment of divided. This is for your information and records. For Concord Biotech Limited Paritosh Trivedi Company Secretary & Compliance Officer ACS 63623 Encl.: As above -------------------------------------------------------------------------------------------------------------------------------------- Regd. Office & Plant : 1482-1486, Trasad Road, Dholka, Dist. Ahmedabad-382225. (India) Phone : +91-2714-222604, 398200 Fax : +91-2714-222504 Website : www.concordbiotech.com MANAGEMENT REPORTS FINANCIAL STATEMENTS CORPORATE OVERVIEW NOTICE 251 NOTICE IS HEREBY GIVEN THAT the 41st Annual General SPECIAL BUSINESS: Meeting of CONCORD BIOTECH LIMITED will be held on 4. APPOINTMENT OF MRS. EKTA GUPTA AS AN Friday, July 31, 2026 through Video Conferencing (“VC”) or Other Audio-Visual Means (“OAVM”) at 12:00 Noon to INDEPENDENT DIRECTOR OF THE COMPANY transact the following business: T o consider and, if thought fit, to pass with or without modification, the following resolution as a ORDINARY BUSINESS: Special Resolution: 1. A DOPTION OF THE ANNUAL AUDITED “ RESOLVED THAT pursuant to the provisions of STANDALONE AND CONSOLIDATED FINANCIAL Sections 149, 150, 152 and other applicable provisions, STATEMENTS AND REPORTS THEREON if any, of the Companies Act, 2013 (‘Act’) (including any statutory modification or re-enactment thereof T o consider and adopt the audited standalone and for the time being in force) read with Schedule IV consolidated financial statements of the Company to the Act, and the Companies (Appointment and for the financial year ended on March 31, 2026, Qualification of Directors) Rules, 2014, Regulations 17, together with the reports of the Board of Directors 25 and other applicable regulations of the Securities and the statutory auditors thereon and in this and Exchange Board of India (Listing Obligations regard, to consider and, if thought fit, to pass the and Disclosure Requirements) Regulations, 2015 following resolution as an Ordinary Resolution: (‘SEBI Listing Regulations’) as amended from “ RESOLVED THAT the Audited Standalone and time to time, and the Articles of Association, and Consolidated Financial Statements of the Company based on the recommendation of the Nomination for the financial year ended on March 31, 2026, and Remuneration Committee and the Board of together with the Reports of the Board of Directors Directors, Mrs. Ekta Gupta (DIN: 01095961), who was and Auditors thereon, as circulated to the Members appointed as an Additional Director of the Company be and are hereby received, considered and with effect from June 01, 2026 and who holds office adopted”. upto the date of this Annual General Meeting and who possesses relevant expertise and experience 2. DECLARATION OF DIVIDEND and has submitted a declaration that she meets the criteria for appointment as an Independent Director T o declare a dividend on equity shares for the as provided under Section 149(6) of the Act and financial year ended on March 31, 2026 and in this Regulation 16(1)(b) of the SEBI Listing Regulations, regard, to consider and if thought fit, to pass the and on receipt of notice in writing under Section following resolution as an Ordinary Resolution: 160(1) of the Companies Act, 2013 from a member of “ RESOLVED THAT as recommended by the Board of the Company proposing her candidature for office of Directors, dividend at the rate of ` 7.55 per Equity Director of the Company, be and is hereby appointed Share i.e. 755% on face value of `1/- each of the as an Independent Director of the Company for a Company, be and is hereby declared for the financial period of 5 consecutive years with effect from June year ended on March 31, 2026.” 01, 2026.” 3. APPOINTMENT OF A DIRECTOR IN PLACE OF 5. APPROVAL OF ENHANCED LIMITS FOR ONE RETIRING BY ROTATION ADVANCING LOANS, PROVIDING GUARANTEES T o appoint a director in place of Mr. Ankur Vaid (DIN: AND SECURITIES TO SUBSIDIARY, ASSOCIATE 01857225), who retires by rotation as a director AND JOINT VENTURE COMPANIES PURSUANT and, being eligible, has offered himself for re- TO SECTION 185 OF THE COMPANIES ACT, appointment and in this regard to consider and, if 2013 thought fit, to pass the following resolution as an T o consider and, if thought fit, to pass with or Ordinary Resolution: without modification, the following resolution as a Special Resolution: “ RESOLVED THAT in accordance with the provisions of Section 152 and other applicable provisions, if any, “ RESOLVED THAT in supersession of the resolution of the Companies Act, 2013 read with Rules made passed by the members of the Company at the thereunder (including any statutory modification(s) Annual General Meeting held on September 09, 2025 or re-enactment(s) thereof for the time being in in this regard and pursuant to Section 185 of the force), Mr. Ankur Vaid (DIN: 01857225), who retires Companies Act, 2013 and Regulation 23 and other by rotation as a Director at the 41st Annual General applicable regulations of SEBI (Listing Obligations Meeting, and being eligible, offers himself for re- and Disclosures Requirements) Regulations, 2015 appointment, be and is hereby re-appointed as a and as recommended by the Audit Committee and Director of the Company.” the Board of Directors of the Company, approval of 62-5202 tropeR launnA 252 members be and is hereby accorded for making of 6. R ATIFICATION OF REMUNERATION OF COST loan(s) including loan represented by way of Book AUDITORS Debt (the “Loan”) to, and/or giving of guarantee(s), T o consider and, if thought fit, to pass the following and/or providing of security(ies) up to a limit not resolution as an Ordinary Resolution: exceeding ` 500 Crores (Rupees Five Hundred Crores only) to below entities: “ RESOLVED THAT pursuant to the provisions of Section 148 and all other applicable provisions of the any subsidiary company, associate company or Companies Act, 2013 read with the Companies (Audit joint venture company of the Company in which and Auditors) Rules, 2014, including any statutory any director of the Company is a director, modification(s), or re-enactment(s) thereof for the member or otherwise interested. time being in force, the consent of the Members of R ESOLVED FURTHER THAT an undertaking shall the Company be and is hereby accorded to ratify the be taken from the Borrowing Company that such remuneration of ` 3,70,000/- (Rupees Three Lakhs loans will be utilized by the borrowing company Seventy Thousand only) plus [Showing first 8,000 characters — download PDF for full document]